Jupiter Life Line Hospitals Ltd
JLHLJupiter Life Line Hospitals Ltd
JLHL
Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹8,091 cr, stock is ranked 551
High RiskStock is 3.57x as volatile as Nifty
1,223.100.90% (-11.05)
1,223.100.90% (-11.05)
Price Chart
High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 55.02 | 22.24 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 53.13 | 5.96 | 0.54% |
Forecast & Ratings
Detailed Forecast100%
Analysts have suggested that investors can buy this stock
from 3 analysts
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Jupiter Life Line Hospitals is a holding company operating three hospitals under the Jupiter brand in Thane, Pune, and Indore, with a total bed capacity of approximately 1,194 hospital beds, specializing in healthcare and related services with expansion plans.
Peers
Compare with peersApollo Hospitals Enterprise Ltd
PE Ratio
104.40
1Y Return
32.43%
Buy Reco %
86.96
Max Healthcare Institute Ltd
PE Ratio
74.01
1Y Return
76.98%
Buy Reco %
73.33
Global Health Ltd
PE Ratio
119.00
1Y Return
181.44%
Buy Reco %
62.50
Fortis Healthcare Ltd
PE Ratio
56.24
1Y Return
68.22%
Buy Reco %
100.00
Narayana Hrudayalaya Ltd
PE Ratio
43.12
1Y Return
70.50%
Buy Reco %
66.67
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
2023
Current
₹1,234.15
Baseline
Forecast for May 2025
High
₹—
Median
₹—
Low
₹—
All values in ₹
2023
Current
₹1,234.15
Baseline
Forecast for May 2025
High
₹—
Median
₹—
Low
₹—
All values in ₹
Revenue Forecast
2023
Current
₹902.96
Baseline
Forecast for Mar 2024
High
₹—
Median
₹—
Low
₹—
All values in ₹ cr.
2023
Current
₹902.96
Baseline
Forecast for Mar 2024
High
₹—
Median
₹—
Low
₹—
All values in ₹ cr.
Earnings Per Share Forecast
2023
Current
₹13.58
Baseline
Forecast for Mar 2024
High
₹—
Median
₹—
Low
₹—
All values in ₹
2023
Current
₹13.58
Baseline
Forecast for Mar 2024
High
₹—
Median
₹—
Low
₹—
All values in ₹
Income
Balance Sheet
Cash Flow
Annual Normal View
Income Statement
Annual Normal View
| Financial Year | FY 2020 | FY 2021 | FY 2022 | FY 2023 | TTM | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 464.84 | 490.27 | 737.14 | 902.96 | 1,041.83 | |||||
Raw Materials | 83.64 | 97.53 | 144.54 | 160.86 | 798.35 | |||||
| Power & Fuel Cost | 16.04 | 15.76 | 15.62 | 22.84 | ||||||
| Employee Cost | 90.11 | 100.98 | 128.98 | 149.70 | ||||||
| Selling & Administrative Expenses | 126.89 | 137.56 | 204.55 | 255.07 | ||||||
| Operating & Other expenses | 63.67 | 67.17 | 86.25 | 104.96 | ||||||
EBITDA | 84.49 | 71.27 | 157.20 | 209.53 | 243.48 | |||||
| Depreciation/Amortization | 25.91 | 30.74 | 36.16 | 38.56 | 41.97 | |||||
| PBIT | 58.58 | 40.53 | 121.04 | 170.97 | 201.51 | |||||
| Interest & Other Items | 25.69 | 38.98 | 43.94 | 42.27 | 36.36 | |||||
| PBT | 32.89 | 1.55 | 77.10 | 128.70 | 165.15 | |||||
| Taxes & Other Items | 3.25 | 3.85 | 25.99 | 55.80 | 18.08 | |||||
| Net Income | 29.64 | -2.30 | 51.11 | 72.90 | 147.07 | |||||
| EPS | 5.83 | -0.45 | 10.05 | 13.58 | 26.02 | |||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Peers & Comparison
Comparing 3 stocks from
Health CareHospitals & Diagnostic Centres
Compare valuation on Screener
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Jupiter Life Line Hospitals Ltd | 111.00 | 22.24 | — |
| Apollo Hospitals Enterprise Ltd | 104.40 | 13.09 | 0.25% |
| Max Healthcare Institute Ltd | 74.01 | 11.02 | 0.12% |
| Global Health Ltd | 119.00 | 15.98 | — |
Price Comparison
Compare JLHL with any stock or ETFCompare JLHL with any stock or ETF
JLHL
Shareholdings
Promoter Holdings Trend
Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Sep 2023
Dec 2023
Mar 2024
Shareholding History
Foreign Institutions
Mutual Funds Holding Trend
A list of mutual funds holding the stock, ranked on the basis of Market-cap held which is calculated as the value of stock held in the portfolio divided by its market cap
Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding Jupiter Life Line Hospitals Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
SBI FUNDS MANAGEMENT PVT LTD#SBI MF-SBI MAGNUM MIDCAP FUND DIRECT PL GROWTH Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 2.8146% | Percentage of the fund’s portfolio invested in the stock 1.35% | Change in the portfolio weight of the stock over the last 3 months 0.01% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 28/77 (0) |
SBI Multicap Fund- Direct Plan- Growth option Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 2.5027% | Percentage of the fund’s portfolio invested in the stock 1.36% | Change in the portfolio weight of the stock over the last 3 months 0.07% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 32/48 (+2) |
SBI Healthcare Opportunities Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 1.2846% | Percentage of the fund’s portfolio invested in the stock 3.95% | Change in the portfolio weight of the stock over the last 3 months -0.19% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 9/30 (+3) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
JLHL has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Dividends
Hmm, looks like data is unavailable here. Please come back after some timeNews & Opinions
Articles & Videos
Hmm, looks like data is unavailable here. Please come back after some time.
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant